Amwell® Announces Results for Second Quarter 2025
Rhea-AI Summary
Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its financial results for the second quarter ended June 30, 2025. The company will discuss these results during a conference call scheduled for 5 p.m. ET on August 5, 2025.
The earnings report is available on the company's investor relations website, and a live audio webcast of the conference call will be accessible online. A replay of the webcast will remain available for approximately 90 days on the investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction 12 Alerts
On the day this news was published, AMWL declined 7.31%, reflecting a notable negative market reaction. Argus tracked a peak move of +11.0% during that session. Argus tracked a trough of -8.7% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $11M from the company's valuation, bringing the market cap to $137M at that time. Trading volume was very high at 4.3x the daily average, suggesting heavy selling pressure.
Data tracked by StockTitan Argus on the day of publication.
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company’s second quarter earnings report may be viewed at investors.amwell.com.
Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast replay will be available for approximately 90 days at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
Press@amwell.com
Investors:
Sue Dooley
sue.dooley@amwell.com
FAQ
When is Amwell (AMWL) reporting Q2 2025 earnings?
Where can I access Amwell's Q2 2025 earnings report?
How long will Amwell's Q2 2025 earnings webcast be available for replay?
What period does Amwell's latest earnings report cover?
